LT3200783T - Eritromelalgijos gydymas - Google Patents
Eritromelalgijos gydymasInfo
- Publication number
- LT3200783T LT3200783T LTEP15790622.3T LT15790622T LT3200783T LT 3200783 T LT3200783 T LT 3200783T LT 15790622 T LT15790622 T LT 15790622T LT 3200783 T LT3200783 T LT 3200783T
- Authority
- LT
- Lithuania
- Prior art keywords
- erythromelalgia
- treatment
- erythromelalgia treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1417497.3A GB201417497D0 (en) | 2014-10-03 | 2014-10-03 | Novel use |
| PCT/GB2015/052885 WO2016051194A1 (en) | 2014-10-03 | 2015-10-02 | Erythromelalgia treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3200783T true LT3200783T (lt) | 2019-09-10 |
Family
ID=51946794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP15790622.3T LT3200783T (lt) | 2014-10-03 | 2015-10-02 | Eritromelalgijos gydymas |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US10231950B2 (lt) |
| EP (1) | EP3200783B1 (lt) |
| CY (1) | CY1122418T1 (lt) |
| DK (1) | DK3200783T3 (lt) |
| ES (1) | ES2751688T3 (lt) |
| GB (1) | GB201417497D0 (lt) |
| HR (1) | HRP20191434T1 (lt) |
| HU (1) | HUE047940T2 (lt) |
| LT (1) | LT3200783T (lt) |
| PL (1) | PL3200783T3 (lt) |
| PT (1) | PT3200783T (lt) |
| RS (1) | RS59479B1 (lt) |
| SI (1) | SI3200783T1 (lt) |
| SM (1) | SMT201900723T1 (lt) |
| WO (1) | WO2016051194A1 (lt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201417497D0 (en) * | 2014-10-03 | 2014-11-19 | Convergence Pharmaceuticals | Novel use |
| JP2019537601A (ja) * | 2016-11-02 | 2019-12-26 | バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. | 新規投薬レジメン |
| KR20210002472A (ko) * | 2018-04-16 | 2021-01-08 | 바이오젠 엠에이 인코포레이티드 | 신경병증성 통증을 치료하는 방법 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO870613L (no) | 1986-03-05 | 1987-09-07 | Molecular Diagnostics Inc | Deteksjon av mikroorganismer i en prve inneholdende nukleinsyre. |
| JP2897959B2 (ja) | 1988-05-20 | 1999-05-31 | エフ.ホフマン―ラ ロシュ アクチェンゲゼルシャフト | 固定化された配列特異的プローブ |
| US5118801A (en) | 1988-09-30 | 1992-06-02 | The Public Health Research Institute | Nucleic acid process containing improved molecular switch |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| ATE198358T1 (de) | 1992-04-27 | 2001-01-15 | Dartmouth College | Detektion von gensequenzen in biologischen flüssigkeiten |
| US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
| US5466823A (en) | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| US5633272A (en) | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
| ES2183935T3 (es) | 1995-02-13 | 2003-04-01 | Searle & Co | Isoxazoles sustituidos para el tratamiento de la inflamacion. |
| UA57002C2 (uk) | 1995-10-13 | 2003-06-16 | Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. | Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування |
| SK285353B6 (sk) | 1996-04-12 | 2006-11-03 | G. D. Searle & Co. | Substituované benzénsulfónamidy ako proliečivá COX-2 inhibítorov, farmaceutická kompozícia a spôsobich prípravy a použitia |
| US6117635A (en) | 1996-07-16 | 2000-09-12 | Intergen Company | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
| US5866336A (en) | 1996-07-16 | 1999-02-02 | Oncor, Inc. | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
| IL127441A (en) | 1996-07-18 | 2003-02-12 | Merck Frosst Canada Inc | Substituted pyridines, pharmaceutical compositions comprising them and their use in the preparation of anti-inflammatory medicaments or as selective cyclooxygenase-2 inhibitors |
| CO4960662A1 (es) | 1997-08-28 | 2000-09-25 | Novartis Ag | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados |
| ES2256817T3 (es) | 1997-09-05 | 2006-07-16 | Glaxo Group Limited | Composiciones farmaceuticas que comprenden derivados de 2,3-diaril-pirazolo(1,5-b)piridazina. |
| HUP0104204A3 (en) | 1998-11-03 | 2002-06-28 | Glaxo Group Ltd | Pyrazolopyridine derivatives as cox-2 inhibitors, process for their preparation and pharmaceutical compositions thereof |
| US6025683A (en) | 1998-12-23 | 2000-02-15 | Stryker Corporation | Motor control circuit for regulating a D.C. motor |
| US6498166B1 (en) | 1999-02-27 | 2002-12-24 | Smithkline Beecham Corporation | Pyrazolopyridines |
| GB0003224D0 (en) | 2000-02-11 | 2000-04-05 | Glaxo Group Ltd | Chemical compounds |
| GB0021494D0 (en) | 2000-09-01 | 2000-10-18 | Glaxo Group Ltd | Chemical comkpounds |
| TW200730494A (en) | 2005-10-10 | 2007-08-16 | Glaxo Group Ltd | Novel compounds |
| WO2008090114A1 (en) * | 2007-01-24 | 2008-07-31 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
| KR102038607B1 (ko) * | 2012-10-15 | 2019-10-30 | 주식회사 대웅제약 | 소디움 채널 차단제, 이의 제조방법 및 이의 용도 |
| CA3082427A1 (en) * | 2013-03-15 | 2014-09-25 | Purdue Pharma L.P. | Carboxamide derivatives and use thereof |
| GB201409851D0 (en) * | 2014-06-03 | 2014-07-16 | Convergence Pharmaceuticals | Diagnostic method |
| GB201417497D0 (en) * | 2014-10-03 | 2014-11-19 | Convergence Pharmaceuticals | Novel use |
| KR102412146B1 (ko) * | 2015-02-11 | 2022-06-22 | 주식회사 아이엔테라퓨틱스 | 소디움 채널 차단제 |
-
2014
- 2014-10-03 GB GBGB1417497.3A patent/GB201417497D0/en not_active Ceased
-
2015
- 2015-10-02 PT PT15790622T patent/PT3200783T/pt unknown
- 2015-10-02 HR HRP20191434TT patent/HRP20191434T1/hr unknown
- 2015-10-02 ES ES15790622T patent/ES2751688T3/es active Active
- 2015-10-02 HU HUE15790622A patent/HUE047940T2/hu unknown
- 2015-10-02 RS RS20190994A patent/RS59479B1/sr unknown
- 2015-10-02 DK DK15790622.3T patent/DK3200783T3/da active
- 2015-10-02 US US15/516,031 patent/US10231950B2/en active Active
- 2015-10-02 EP EP15790622.3A patent/EP3200783B1/en active Active
- 2015-10-02 PL PL15790622T patent/PL3200783T3/pl unknown
- 2015-10-02 WO PCT/GB2015/052885 patent/WO2016051194A1/en not_active Ceased
- 2015-10-02 SI SI201530856T patent/SI3200783T1/sl unknown
- 2015-10-02 SM SM20190723T patent/SMT201900723T1/it unknown
- 2015-10-02 LT LTEP15790622.3T patent/LT3200783T/lt unknown
-
2019
- 2019-01-22 US US16/254,251 patent/US20190388391A1/en not_active Abandoned
- 2019-10-31 CY CY20191101134T patent/CY1122418T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2751688T3 (es) | 2020-04-01 |
| RS59479B1 (sr) | 2019-12-31 |
| CY1122418T1 (el) | 2021-01-27 |
| SMT201900723T1 (it) | 2020-03-13 |
| EP3200783A1 (en) | 2017-08-09 |
| GB201417497D0 (en) | 2014-11-19 |
| SI3200783T1 (sl) | 2020-03-31 |
| WO2016051194A1 (en) | 2016-04-07 |
| PL3200783T3 (pl) | 2020-01-31 |
| US20170304264A1 (en) | 2017-10-26 |
| EP3200783B1 (en) | 2019-07-31 |
| US10231950B2 (en) | 2019-03-19 |
| DK3200783T3 (da) | 2019-08-05 |
| HRP20191434T1 (hr) | 2020-10-02 |
| PT3200783T (pt) | 2019-08-21 |
| US20190388391A1 (en) | 2019-12-26 |
| HUE047940T2 (hu) | 2020-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL250387A0 (en) | combined treatment | |
| IL248856B (en) | New treatment | |
| GB201502137D0 (en) | Treatment | |
| GB201405033D0 (en) | Combination therapy | |
| GB201608885D0 (en) | Treatment | |
| GB201522243D0 (en) | Treatment | |
| ZA201702522B (en) | Combination therapy | |
| GB201508841D0 (en) | Treatment | |
| GB201402179D0 (en) | Surface treatment | |
| PL3200783T3 (pl) | Leczenie erytromelalgii | |
| ZA201608217B (en) | Combination therapy | |
| GB201411027D0 (en) | Treatment | |
| GB201503008D0 (en) | Treatment | |
| GB201412411D0 (en) | Treatment | |
| GB201617107D0 (en) | Treatment | |
| GB201413317D0 (en) | Atheroscierosis treatment | |
| GB201412410D0 (en) | Treatment | |
| GB201400241D0 (en) | Treatment | |
| GB201400240D0 (en) | Treatment | |
| GB201400235D0 (en) | Treatment | |
| GB201400238D0 (en) | Treatment | |
| GB201400239D0 (en) | Treatment | |
| GB201612260D0 (en) | Treatment | |
| GB201612193D0 (en) | Treatment | |
| GB201609683D0 (en) | Treatment |